Hong J, Lee JH, Zhang Z, Wu Y, et al. PRC2-mediated epigenetic suppression of type I IFN-STAT2 signaling impairs antitumor immunity in luminal breast cancer. Cancer Res 2022 Oct 12. pii: 709714. doi: 10.1158/0008-5472.CAN-22-0736.
PMID: 36222718